This inventor holds 1 USPTO granted patent. Top assignee: Agilent Technologies, Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Nancy McKinney: Innovator in DNA Polymerase Technology
Introduction
Nancy McKinney is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of DNA polymerases. Her work focuses on enhancing the efficiency and effectiveness of polymerase enzymes used in various applications.
Latest Patents
Nancy McKinney holds a patent for "Thermostable type-A DNA polymerase mutants with increased polymerization rate and resistance to inhibitors." This invention provides mutants of DNA polymerases that exhibit an increased rate of nucleotide incorporation into nucleic acids during polymerization. Additionally, these mutants demonstrate enhanced resistance to inhibitors that typically affect DNA polymerase activity. The mutant polymerases are particularly well-suited for fast PCR applications, especially in samples containing inhibitors of wild-type polymerases. In exemplary embodiments, the mutants are derived from Taq DNA polymerase.
Career Highlights
Nancy McKinney is associated with Agilent Technologies, Inc., where she continues to innovate in the field of molecular biology. Her work has been instrumental in advancing PCR technology, which is crucial for various research and diagnostic applications.
Collaborations
Nancy collaborates with talented professionals in her field, including Holly Hogrefe and Michelle H Cayouette. These collaborations enhance the research and development efforts at Agilent Technologies, Inc.
Conclusion
Nancy McKinney's contributions to DNA polymerase technology exemplify her commitment to innovation in biotechnology. Her patented work not only advances scientific understanding but also improves practical applications in molecular biology.